TrialPsychopharmacology2016

Incidence of non-alcoholic fatty liver disease and metabolic dysfunction in first episode schizophrenia and related psychotic disorders: a 3-year prospective randomized interventional study.

María José Morlán-Coarasa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.